Replies to post #124548 on Anavex Life Sciences Corp (AVXL)

[nidan7500]

Bourbon...agree with your assessment...these are not random events

So...it makes perfect sense to stay mum about the second P2a data...if you publicize it, the market still wont fully recognize it. But a sophisticated BP would understand, and AVXL would be in danger of being bought out on the cheap

He has planned the sequence PR/NEWS/conferences to build upon each other over time, IMO. I expect each session/process step will incrementally build the credibility and content of medical science and AVXL competence. As you say, why throw big $$$ at P3 if you are doing a crap shoot as has been the case for years? With more data, results and plans being published the investor risk is mitigated and confidence builds. Brilliant.

[Rubyred77]

Nice reminder of what Missling has said, and how he is executing. Sticky for "unsophisticated investors" to discover.

[Jonjones325]

From Bourbon's post. "Of course there has been reasonable speculation that what this is really doing is confirming the first P2a, with the doses optimized. "

If Missling does indeed do this, doesn't it warrant Accelerated Approval?

Maybe one of the "considerable" number of filings Fadiran was talking about.